• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

速尿对支气管肺发育不良婴儿肺功能的短期和长期影响。

Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia.

作者信息

Engelhardt B, Elliott S, Hazinski T A

出版信息

J Pediatr. 1986 Dec;109(6):1034-9. doi: 10.1016/s0022-3476(86)80295-5.

DOI:10.1016/s0022-3476(86)80295-5
PMID:3537245
Abstract

Although furosemide improves lung mechanics in some infants with broncho-pulmonary dysplasia (BPD), this may not be important unless gas exchange also improves. To determine the relationship between improvement in mechanics and improvement in gas exchange, the short- and long-term effects of furosemide therapy were studied in 16 spontaneously breathing infants with severe BPD who were both oxygen dependent and hypercarbic (mean PCO2 54 +/- 11 torr). Each infant was examined at least three times: before furosemide therapy, 1 hour after the first dose of furosemide, and after a 6- to 10-day course. Ten of the 16 infants were also examined three times during a 7-day control period. Transcutaneous PO2 and PCO2, esophageal pressure, air flow, and tidal volume were measured. Pulmonary resistance, lung compliance, and the alveolar to skin PO2 difference were calculated. After a single dose of furosemide, only compliance significantly improved. After prolonged therapy, compliance, resistance, and oxygenation significantly improved in the group as a whole, but better oxygenation was achieved in only six of 16 infants. tcPCO2 was unaffected by long-term furosemide therapy, but in all infants with decreased tcPCO2 1 hour after a single dose, there was sustained decrease in PCO2 after prolonged therapy. Changes in gas exchange were not explained by changes in lung mechanics. These data indicate that long-term diuretic therapy can improve the mechanical properties of the lungs of spontaneously breathing infants with BPD, but that gas exchange is usually unaffected.

摘要

尽管速尿可改善一些支气管肺发育不良(BPD)婴儿的肺力学,但除非气体交换也得到改善,否则这可能并不重要。为了确定力学改善与气体交换改善之间的关系,我们对16名患有严重BPD、依赖氧气且有高碳酸血症(平均PCO2 54±11托)的自主呼吸婴儿进行了速尿治疗的短期和长期效果研究。每个婴儿至少接受三次检查:速尿治疗前、首次服用速尿后1小时以及经过6至10天疗程后。16名婴儿中的10名在7天的对照期内也接受了三次检查。测量了经皮PO2和PCO2、食管压力、气流和潮气量。计算了肺阻力、肺顺应性以及肺泡与皮肤PO2差值。单次服用速尿后,只有顺应性显著改善。长期治疗后,整个组的顺应性、阻力和氧合均显著改善,但16名婴儿中只有6名的氧合情况有所改善。长期速尿治疗对tcPCO2无影响,但在单次服用速尿后1小时tcPCO2降低的所有婴儿中,长期治疗后PCO2持续降低。气体交换的变化无法用肺力学的变化来解释。这些数据表明,长期利尿治疗可改善患有BPD的自主呼吸婴儿的肺机械性能,但气体交换通常不受影响。

相似文献

1
Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia.速尿对支气管肺发育不良婴儿肺功能的短期和长期影响。
J Pediatr. 1986 Dec;109(6):1034-9. doi: 10.1016/s0022-3476(86)80295-5.
2
Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia.速尿可急性降低慢性支气管肺发育不良患者的气道阻力。
J Pediatr. 1983 Oct;103(4):624-9. doi: 10.1016/s0022-3476(83)80602-7.
3
Double-blind, placebo-controlled trial of alternate-day furosemide therapy in infants with chronic bronchopulmonary dysplasia.慢性支气管肺发育不良婴儿隔日使用速尿治疗的双盲、安慰剂对照试验。
J Pediatr. 1990 Jul;117(1 Pt 1):112-8. doi: 10.1016/s0022-3476(05)82458-8.
4
Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia.吸入速尿对重度支气管肺发育不良通气婴儿的肺部影响。
Pediatrics. 1997 Jan;99(1):71-5. doi: 10.1542/peds.99.1.71.
5
Nebulized furosemide in infants with bronchopulmonary dysplasia.雾化呋塞米用于支气管肺发育不良婴儿
J Pediatr. 1994 Dec;125(6 Pt 1):976-9. doi: 10.1016/s0022-3476(05)82018-9.
6
Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia.长期利尿疗法治疗依赖氧的支气管肺发育不良婴儿的随机试验。
J Pediatr. 1994 May;124(5 Pt 1):772-81. doi: 10.1016/s0022-3476(05)81373-3.
7
Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia.咖啡因给药对支气管肺发育不良婴儿肺力学的影响。
Pediatr Pulmonol. 1989;6(1):49-52. doi: 10.1002/ppul.1950060112.
8
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.用于患有(或正在发展为)慢性肺病的早产儿的静脉或肠内袢利尿剂。
Cochrane Database Syst Rev. 2000(4):CD001453. doi: 10.1002/14651858.CD001453.
9
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.用于患有(或正在发展为)慢性肺病的早产儿的静脉或肠内袢利尿剂。
Cochrane Database Syst Rev. 2000(2):CD001453. doi: 10.1002/14651858.CD001453.
10
Bronchodilators and diuretics in children with bronchopulmonary dysplasia.支气管肺发育不良患儿使用支气管扩张剂和利尿剂的情况。
Pediatr Pulmonol. 1985 Jul-Aug;1(4):198-203. doi: 10.1002/ppul.1950010406.

引用本文的文献

1
An Update on the Prevention and Management of Bronchopulmonary Dysplasia.支气管肺发育不良的预防与管理最新进展
Pediatric Health Med Ther. 2021 Aug 11;12:405-419. doi: 10.2147/PHMT.S287693. eCollection 2021.
2
Association Between Furosemide Exposure and Clinical Outcomes in a Retrospective Cohort of Critically Ill Children.在一个危重症儿童回顾性队列中,速尿暴露与临床结局之间的关联。
Front Pediatr. 2021 Jan 25;8:589124. doi: 10.3389/fped.2020.589124. eCollection 2020.
3
Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge.
重度支气管肺发育不良中使用袢利尿剂:累积使用与死亡率和出院时年龄的关系。
J Pediatr. 2021 Apr;231:43-49.e3. doi: 10.1016/j.jpeds.2020.10.073. Epub 2020 Nov 3.
4
Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study.极低出生体重儿利尿剂治疗的急性反应:来自早产儿和呼吸结局计划队列研究的结果。
J Pediatr. 2018 Jun;197:42-47.e1. doi: 10.1016/j.jpeds.2018.01.066. Epub 2018 Mar 26.
5
Updates on Functional Characterization of Bronchopulmonary Dysplasia - The Contribution of Lung Function Testing.支气管肺发育不良的功能特征更新——肺功能测试的贡献。
Front Med (Lausanne). 2015 May 29;2:35. doi: 10.3389/fmed.2015.00035. eCollection 2015.
6
Unexpected extra-renal effects of loop diuretics in the preterm neonate.利尿剂在早产儿中的意外肾脏外作用。
Acta Paediatr. 2012 Aug;101(8):835-45. doi: 10.1111/j.1651-2227.2012.02699.x. Epub 2012 May 28.
7
Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.静脉注射或肠内给予袢利尿剂用于患有(或正在发展为)慢性肺病的早产儿。
Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD001453. doi: 10.1002/14651858.CD001453.pub2.
8
Hypertension in infancy: diagnosis, management and outcome.婴儿期高血压:诊断、治疗与预后。
Pediatr Nephrol. 2012 Jan;27(1):17-32. doi: 10.1007/s00467-010-1755-z. Epub 2011 Jan 22.
9
Urinary aldosterone excretion and electrolytic balance in response to chronic diuretic therapy in very low-birth weight infants.极低出生体重儿慢性利尿治疗时的尿醛固酮排泄和电解质平衡。
J Endocrinol Invest. 2011 Sep;34(8):604-8. doi: 10.3275/7330. Epub 2010 Nov 8.
10
A risk-benefit assessment of drugs used for neonatal chronic lung disease.用于新生儿慢性肺病药物的风险效益评估。
Drug Saf. 2000 May;22(5):389-404. doi: 10.2165/00002018-200022050-00006.